PediRISE Feasibility
The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program.

The names of the study groups in this research study are:

PediRISE Program Group
Usual Care Group
- EligibilityCriteria: Inclusion Criteria:  Child diagnosed with de novo cancer Child has established care at a study site and initiated cancer-directed therapy in the prior 2-months Child planned to receive at least 4-months of cancer-directed therapy at study site from time of diagnosis per initial cancer treatment plan Child is <18 years at time of enrollment Parent/guardian screened positive for self-reported low-income (<200% FPL). Family primary residence in MA, NY or NJ Provider approval for permission to approach  Exclusion Criteria:  Planned transfer of child to a non-DFCI or non-Columbia facility for cancer-directed therapy Foreign national family receiving care as an Embassy-pay patient Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, AHOD2131, ANBL2131, DFCI 23-001). Child or household member receiving SSI. - HealthyVolunteers: No - Gender: All - MaximumAge: 17 Years - StdAgeList: Child